Ogilvy was approved for production by the US Food and Drug Administration in China in the 1990s, that is, from1February 1999 to1February 5. As a new type of non-toxic, environmentally friendly and low heterosexual artificial fat, it is put into use. It was officially put into mass production in 2000 and widely used in plastic surgery industry, from simple rhinoplasty to temple breast augmentation.

As a liquid injection material, Ogilvy is powerful, quick and effective. Ogilvy, as the breast of women's second face, has become the best material for breast augmentation. It became popular all over the country in a short time, and women who love beauty invariably went to the hospital for breast augmentation surgery. As a composite material, Ogilvy is non-toxic and has excellent compatibility with human body. However, after it was widely used in China, its disadvantages also appeared. It is harmful to the human body after it is decomposed into monomers in the human body. It will affect people's nervous system, cause endocrine disorders and cause cancer. In a few years, hundreds of thousands of women with breast augmentation have different degrees of complications. Ogilvy causes breast inflammation, infection, breast deformation, and more seriously, it will force mastectomy, which will bring lifelong pain to friends who inject Ogilvy.